Cargando…
Response to: Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IMSS. Published by Elsevier Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833747/ https://www.ncbi.nlm.nih.gov/pubmed/33483150 http://dx.doi.org/10.1016/j.arcmed.2020.12.014 |
| _version_ | 1783642134011707392 |
|---|---|
| author | Ita, Kevin |
| author_facet | Ita, Kevin |
| author_sort | Ita, Kevin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7833747 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | IMSS. Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78337472021-01-26 Response to: Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development Ita, Kevin Arch Med Res Letter to the Editor IMSS. Published by Elsevier Inc. 2021-05 2021-01-11 /pmc/articles/PMC7833747/ /pubmed/33483150 http://dx.doi.org/10.1016/j.arcmed.2020.12.014 Text en © 2021 IMSS. Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Ita, Kevin Response to: Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development |
| title | Response to: Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development |
| title_full | Response to: Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development |
| title_fullStr | Response to: Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development |
| title_full_unstemmed | Response to: Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development |
| title_short | Response to: Regarding the Article: Coronavirus Disease (COVID-19): Current Status and Prospects for Drug and Vaccine Development |
| title_sort | response to: regarding the article: coronavirus disease (covid-19): current status and prospects for drug and vaccine development |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7833747/ https://www.ncbi.nlm.nih.gov/pubmed/33483150 http://dx.doi.org/10.1016/j.arcmed.2020.12.014 |
| work_keys_str_mv | AT itakevin responsetoregardingthearticlecoronavirusdiseasecovid19currentstatusandprospectsfordrugandvaccinedevelopment |